SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001005150-02-000729
Filing Date
2002-05-20
Accepted
2002-05-20 14:48:05
Documents
1
Period of Report
2001-06-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A formnps.txt DEF 14A 107106
  Complete submission text file 0001005150-02-000729.txt   108734
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15070 | Film No.: 02657460
SIC: 2834 Pharmaceutical Preparations